Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
27 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
31
31 articles ont été cités au moins 31fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
8 861
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
93
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
52
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Hôpital Foch
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review
2025ArticleJournal of Clinical Immunology
Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients
2025ArticleJournal of Human Immunity
The impact of allogeneic hematopoietic stem cell transplantation on pulmonary complications in adults with inborn errors of immunity
2025ArticleJournal of Allergy and Clinical Immunology
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
2024ArticleJournal of Experimental Medicine
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
2024ArticleRespiratory Research
Anti–IL-4R versus anti–IL-5/5R after anti–IL-5/5R failure in asthma: An emulated target trial
2024ArticleJournal of Allergy and Clinical Immunology
Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France
2024ArticleEmerging Infectious Diseases
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
2024ArticleGenome Medicine
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
HOPITAL FOCH
40 R WORTH BP 36, 92151 SURESNES CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Journal of experimental medicine · 2020
Autosomal dominant hyper-IgE syndrome (AD-HIES) is typically caused by dominant-negative (DN) STAT3 mutations. Patients suffer from cold staphylococcal lesions and mucocutaneous candidiasis, severe allergy, and skeletal abnormalities. We report 12 patients from 8 unrelated kindreds with AD-HIES due to DN IL6ST mutations. We identified seven different truncating mutations, one of which was recurrent. The mutant alleles encode GP130 receptors bearing the transmembrane domain but lacking both the recycling motif and all four STAT3-recruiting tyrosine residues. Upon overexpression, the mutant proteins accumulate at the cell surface and are loss of function and DN for cellular responses to IL-6, IL-11, LIF, and OSM. Moreover, the patients’ heterozygous leukocytes and fibroblasts respond poorly to IL-6 and IL-11. Consistently, patients with STAT3 and IL6ST mutations display infectious and allergic manifestations of IL-6R deficiency, and some of the skeletal abnormalities of IL-11R deficiency. DN STAT3 and IL6ST mutations thus appear to underlie clinical phenocopies through impairment of the IL-6 and IL-11 response pathways.
The European respiratory journal · 2015
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by failure of superoxide production in phagocytic cells. The disease is characterised by recurrent infections and inflammatory events, frequently affecting the lungs. Improvement of life expectancy now allows most patients to reach adulthood. We aimed to describe the pattern of pulmonary manifestations occurring during adulthood in CGD patients. This was a retrospective study of the French national cohort of adult patients (≥16 years old) with CGD. Medical data were obtained for 67 adult patients. Pulmonary manifestations affected two-thirds of adult patients. Their incidence was significantly higher than in childhood (mean annual rate 0.22 versus 0.07, p=0.01). Infectious risk persisted despite anti-infectious prophylaxis. Invasive fungal infections were frequent (0.11 per year per patient) and asymptomatic in 37% of the cases. They often required lung biopsy for diagnosis (10 out of 30). Noninfectious respiratory events concerned 28% of adult patients, frequently associated with a concomitant fungal infection (40%). They were more frequent in patients with the X-linked form of CGD. Immune-modulator therapies were required in most cases (70%). Respiratory manifestations are major complications of CGD in adulthood. Noninfectious pulmonary manifestations are as deleterious as infectious pneumonia. A specific respiratory monitoring is necessary.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
American journal of respiratory and critical care medicine · 2026 · Journal Article
Couderc LJ, Grassin-Delyle S, Devillier P, Catherinot E, et al.
The Journal of experimental medicine · 2024 · Journal Article
Rosain J, Le Voyer T, Liu X, Gervais A, et al.
Respiratory medicine and research · 2024 · Case Reports
Couderc LJ, Fleury-Feith J, Longchampt E, Wagner I, et al.
Diagnostic microbiology and infectious disease · 2023 · Journal Article
Martin EC, Limousin L, Renaux C, Catherinot E, et al.
The Journal of allergy and clinical immunology · 2023 · Journal Article
Zhang Y, Lin T, Leung HM, Zhang C, et al.
Open forum infectious diseases · 2022 · Journal Article
Chiron R, Hoefsloot W, Van Ingen J, Marchandin H, et al.
Bone marrow transplantation · 2022 · Journal Article
Marçais A, Mahlaoui N, Neven B, Lanternier F, et al.
The Journal of experimental medicine · 2020 · Journal Article
Béziat V, Tavernier SJ, Chen YH, Ma CS, et al.
Emerging infectious diseases · 2019 · Case Reports
Paccoud O, Guery R, Poirée S, Jouvion G, et al.
The journal of allergy and clinical immunology. In practice · 2019 · Journal Article
Duréault A, Tcherakian C, Poiree S, Catherinot E, et al.
Medical mycology case reports · 2018 · Journal Article
Point S, Gabriel F, Bégueret H, Jougon J, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017 · Journal Article
Dunogué B, Pilmis B, Mahlaoui N, Elie C, et al.
Infectious disease clinics of North America · 2017 · Journal Article
Lanternier F, Ader F, Pilmis B, Catherinot E, et al.
Journal of clinical immunology · 2017 · Case Reports
Colin de Verdière S, Noel E, Lozano C, Catherinot E, et al.
Seminars in respiratory and critical care medicine · 2015 · Journal Article
Danion F, Aguilar C, Catherinot E, Alanio A, et al.
The European respiratory journal · 2015 · Journal Article
Salvator H, Mahlaoui N, Catherinot E, Rivaud E, et al.
The American journal of tropical medicine and hygiene · 2014 · Case Reports
Richaud C, Chandesris MO, Lanternier F, Benzaquen-Forner H, et al.
American journal of respiratory and critical care medicine · 2014 · Case Reports
Didier M, Guedin P, Staub F, Catherinot E, et al.
Journal of clinical immunology · 2025 · Journal Article
Lefevre L, Paccoud O, Neven B, Bougnoux ME, et al.
European radiology · 2024 · Journal Article
Grenier PA, Brun AL, Longchampt E, Lipski M, et al.
Medicine · 2015 · Case Reports
Chaussade H, Lebeaux D, Gras G, Catherinot E, et al.
The Journal of allergy and clinical immunology · 2023 · Journal Article
Maccari ME, Wolkewitz M, Schwab C, Lorenzini T, et al.
Journal of thoracic disease · 2021 · Journal Article
Taverne J, Salvator H, Leboulch C, Barizien N, et al.
Journal of clinical immunology · 2020 · Published Erratum
Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, et al.
Journal of clinical immunology · 2019 · Journal Article
Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, et al.
The Journal of allergy and clinical immunology · 2013 · Journal Article
Noel N, Mahlaoui N, Blanche S, Suarez F, et al.
Virus research · 2023 · Journal Article
Coppée R, Chenane HR, Bridier-Nahmias A, Tcherakian C, et al.
The Journal of allergy and clinical immunology · 2013 · Journal Article
Noel N, Mahlaoui N, Blanche S, Suarez F, et al.
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Abstract Conventional immunosuppressants are ineffective for the management of EGPA-related asthma. Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TLSP) that has proven efficacy in
Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma
Abstract Conventional immunosuppressants are ineffective for the management of EGPA-related asthma. Tezepelumab is a human monoclonal antibody that inhibits thymic stromal lymphopoietin (TLSP) that has proven efficacy in
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).